[1]
A. Andreza and A. N. Widayati, “Effect of Dapagliflozin in Lowering Risk of Heart Failure Severity: Meta-Analysis”, J Epidemiol Public Healt, vol. 8, no. 1, pp. 25–34, Jan. 2023.